Fennec Pharmaceuticals Inc. Insider Trading Activity
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
3 txns
Insider
RALLIS CHRIS A
Role
Director
Sold
1,119 shs ($10K)
Approx. gross sale proceeds
$10K
Approx. exercise cost
$5K
Share of Position Sold
2.0%
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Common Shares | 2,127 | $2.35 | $5K |
| Exercise | Common Shares | 2,127 | $2.35 | $5K |
| Sale | Common Shares | 1,119 | $8.71 | $10K |
Holdings After Transaction:
Common Shares — 178,406 shares (Direct);
Common Shares — 54,792 shares (Direct)
Holdings Before and After:
Common Shares, 180,533 to 178,406 shares (Direct);
Common Shares, 53,784 to 54,792 shares (Direct)
Other Insiders: 1 other insider reported open-market sales of this stock in the 30 days up to this filing.
Footnotes (3)
- F1. Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on August 17, 2023.
- F2. Shares sold to satisfy tax obligation on option exercise.
- F3. Represents options exercised pursuant to a 10b5-1 plan adopted on August 17, 2023.
AI-generated analysis. How Rhea-AI works. Not financial advice.